![](/img/cover-not-exists.png)
A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti‐CD40 monoclonal antibody, in kidney transplantation
Vincenti, Flavio, Klintmalm, Goran, Yang, Harold, Peddi, V. Ram, Blahunka, Paul, Conkle, Angela, Santos, Vicki, Holman, JohnLanguage:
english
Journal:
American Journal of Transplantation
DOI:
10.1111/ajt.15560
Date:
August, 2019
File:
PDF, 661 KB
english, 2019